EXOVITA BIOSCIENCES
Exovita Biosciences is an early-stage biotech company developing exosome-based cancer therapeutics. The company's technology is based on research by Kristina Trujillo (Assistant Professor, UNM Health Sciences’ Department of Cell Biology and Physiology). Trujillo helped discover cancer-killing properties in exosomes (vesicles or fluid-filled packets, that the body forms for cells to communicate with each other). Exosomes have highly selective toxicity against the tumor cells. Exovita is supported by New Mexico Startup Factory, the University of New Mexico Health Sciences Center, STC.UNM, and Peacock Myers.
EXOVITA BIOSCIENCES
Industry:
Biotechnology Health Care Insurance Medical
Founded:
2014-01-01
Address:
Albuquerque, New Mexico, United States
Country:
United States
Website Url:
http://www.exovitabiotech.com
Total Employee:
11+
Status:
Closed
Contact:
1-505-843-4206
Email Addresses:
[email protected]
Total Funding:
9 K USD
Technology used in webpage:
SPF Facebook Sharer Twitter Tweet Button Namecheap DNS Namecheap Hosting Namecheap
Founder
Official Site Inspections
http://www.exovitabiotech.com
- Host name: 172-236-126-225.ip.linodeusercontent.com
- IP address: 172.236.126.225
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Exovita Biosciences"
Exovita Biosciences - Crunchbase Company Profile
Organization. Exovita Biosciences . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. About. ... Contact Email …See details»
Exovita Biosciences, Inc.: Drug pipelines, Patents, Clinical trials ...
Jul 13, 2023 New Mexico, United States | exovitabiotech.com exovitabiotech.com. Last update 31 May 2023See details»
Exovita Biosciences Company Profile 2024: Valuation, Funding ...
Exovita Biosciences General Information Description. Developer of exosome-based cancer therapeutics. The company helps in leveraging the technology and resulting therapeutics to …See details»
ExoVita Biosciences - VentureRadar
Website: http://exovitabiotech.com. Exovita Biosciences is developing potentially transformative, exosome-based cancer therapeutics that harness the body’s natural ...See details»
ExoVita Biosciences - VentureRadar
DANISH BIOTECH is a trade organization for Danish biotech companies with the aim to promote opportunities for biotechnology research, development and production in Denmark and …See details»
Exovita Biosciences - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Mar 2, 2015: Seed Round - …See details»
Exovita Biosciences - Company Profile - Tracxn
Exovita Biosciences - US-based, early-stage biotech, developing exosome-based cytotoxic therapeutics for cancer. Raisedfunding over 4 rounds from 2 investors. Exovita Biosciences …See details»
Exovita Biosciences - Owler
Exovita Biosciences develops transformative and exosome-based cancer therapeutics medicines. Exovita Biosciences’s primary competitors include Codiak, Exosome Diagnostics, True Health …See details»
Exovita Biosciences - Tech Stack, Apps, Patents & Trademarks
Exovita Biosciences is an early-stage biotech company developing exosome-based cancer therapeutics.See details»
Exovita Biosciences Careers, Perks + Culture - Built In
Learn more about Exovita Biosciences. Find jobs, explore benefits, and research company culture at Built In.See details»
Startup Wins $1.7M NIH Grant for Exosome-Based Cancer …
Jun 9, 2015 A startup working to commercialize exosome-based cancer therapeutics has won a $1.7 million grant from NIH’s National Cancer Institute for research toward developing the …See details»
NIH Awards $1.7 Million to Advance Exosome-Based Cancer Drug …
Jun 9, 2015 ALBUQUERQUE, N.M.--(BUSINESS WIRE)--The National Institutes of Health (NIH) National Cancer Institute has awarded a five-year, $1.7 million grant to the University of New …See details»
Exovita Biosciences Awarded $1.7M NIH Grant - Technology …
Jun 10, 2015 Exovita holds an option to an exclusive, worldwide license for the patent-pending technology with STC.UNM, the technology-transfer and economic-development organization …See details»
NIH Awards $1.7 Million Grant to Exosome Start-Up Company …
Jun 13, 2015 The National Institutes of Health (NIH) National Cancer Institute has awarded a five-year, $1.7 million grant to the University of New Mexico (UNM) Health Sciences Center to …See details»
NIH Awards $1.7 Million To Advance Exosome-Based Cancer Drug …
Jun 9, 2015 ALBUQUERQUE, N.M.--(BUSINESS WIRE)--The National Institutes of Health (NIH) National Cancer Institute has awarded a five-year, $1.7 million grant to the University of New …See details»
NIH Awards $1.7 Million to Advance Exosome-Based Cancer Drug …
Jun 9, 2015 The National Institutes of Health National Cancer Institute has awarded a five-year, $1.7 million grant to the University of New Mexico Health Sciences Center to advance the …See details»
NIH Awards $1.7 Million to Advance Exosome-Based Cancer Drug …
Jun 9, 2015 Release Summary. The NIH has awarded a 5-year, $1.7 million grant to the University of New Mexico Health Sciences Center to advance exosome-based cancer drug …See details»
NIH Awards $1.7 Million To Advance Exosome-Based Cancer Drug …
Jun 9, 2015 Best Places to Work; Employer Resources; Post Jobs; Talent Solutions; Advertise; Submit a Press ReleaseSee details»
Biological Dynamics launches ExoVita™ Pancreas and enrolls …
Feb 8, 2023 Biological Dynamics, Inc., a company commercializing its exosome-isolation ExoVeritaâ„¢ platform for early disease surveillance and other applications, today announced …See details»
Biological Dynamics launches ExoVita™ Pancreas and enrolls …
Feb 21, 2023 Excerpt from the Press Release: AN DIEGO–(BUSINESS WIRE)–Biological Dynamics, Inc., a company commercializing its exosome-isolation ExoVeritaâ„¢ platform for …See details»